Oxford BioMedica reiterates FY2026 guidance
- ByInvesting.com-
Investing.com -- Oxford BioMedica (LSE:OXB) has reaffirmed its full-year 2026 guidance, expecting revenue of £220-240 million at...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 1,886.60 | 1,911.00 | 1,839.20 | +68.70 | +3.78% | 2.54M | ||
| 7,580.50 | 7,612.50 | 7,437.50 | +167.50 | +2.26% | 450.04K | ||
| 2,270.20 | 2,289.70 | 2,222.00 | +52.90 | +2.39% | 1.27M | ||
| 1,222.10 | 1,239.00 | 1,198.00 | +29.40 | +2.46% | 9.65M | ||
| 9,048.50 | 9,149.50 | 8,981.00 | +150.50 | +1.69% | 438.76K | ||
| 882.75 | 888.80 | 853.30 | +33.75 | +3.98% | 16M | ||
| 1,746.20 | 1,765.00 | 1,717.60 | +41.80 | +2.45% | 1.87M | ||
| 1,834.90 | 1,849.20 | 1,810.10 | +32.80 | +1.82% | 12.47M | ||
| 413.45 | 422.00 | 412.55 | -1.00 | -0.24% | 15.13M | ||
| 1,244.40 | 1,252.90 | 1,219.00 | +25.00 | +2.05% | 1.47M | ||
| 443.70 | 446.40 | 438.80 | +1.60 | +0.36% | 8.63M | ||
| 1,300.70 | 1,309.00 | 1,260.10 | +41.10 | +3.26% | 1.58M | ||
| 6,992.50 | 7,073.00 | 6,904.00 | +121.50 | +1.77% | 490.39K | ||
| 2,647.80 | 2,668.40 | 2,561.80 | +98.40 | +3.86% | 1.66M | ||
| 1,381.30 | 1,411.40 | 1,348.00 | +8.00 | +0.58% | 4.17M | ||
| 782.30 | 794.80 | 768.20 | +17.40 | +2.27% | 59.23M | ||
| 5,289.50 | 5,364.00 | 5,278.00 | +36.50 | +0.69% | 531.7K | ||
| 2,134.80 | 2,154.70 | 2,086.00 | +49.80 | +2.39% | 2.07M | ||
| 868.65 | 874.80 | 862.30 | +14.00 | +1.64% | 4.49M | ||
| 1,259.70 | 1,272.90 | 1,254.40 | +8.50 | +0.68% | 17.29M | ||
| 818.40 | 834.30 | 802.95 | +21.15 | +2.65% | 3.1M | ||
| 1,279.10 | 1,290.60 | 1,257.10 | +0.80 | +0.06% | 10.82M | ||
| 295.70 | 298.50 | 292.25 | +4.45 | +1.53% | 26.18M | ||
| 1,156.00 | 1,170.10 | 1,137.30 | +22.30 | +1.97% | 1.63M | ||
| 371.10 | 378.00 | 363.00 | +4.25 | +1.16% | 42.44M | ||
| 3,649.30 | 3,660.00 | 3,546.00 | +132.50 | +3.77% | 5.09M | ||
| 3,128.10 | 3,157.90 | 3,082.90 | +96.80 | +3.19% | 3.33M | ||
| 12,711.00 | 12,780.00 | 12,506.00 | +247.00 | +1.98% | 540.65K | ||
| 1,375.90 | 1,392.70 | 1,354.80 | +31.70 | +2.36% | 1.86M | ||
| 378.40 | 380.95 | 375.60 | +2.85 | +0.76% | 9.27M | ||
| 270.20 | 271.50 | 266.40 | +2.15 | +0.80% | 13.38M | ||
| 295.00 | 302.25 | 294.20 | -4.00 | -1.34% | 16.42M | ||
| 1,413.10 | 1,430.50 | 1,408.40 | +1.30 | +0.09% | 19.04M | ||
| 1,060.60 | 1,065.50 | 1,043.00 | +29.80 | +2.89% | 16.21M | ||
| 956.00 | 965.00 | 917.30 | +52.40 | +5.80% | 14.27M | ||
| 1,795.40 | 1,809.50 | 1,755.50 | +42.10 | +2.40% | 1.9M | ||
| 2,377.40 | 2,421.60 | 2,369.80 | -21.40 | -0.89% | 5.84M | ||
| 1,056.10 | 1,073.00 | 1,050.60 | +3.00 | +0.28% | 1.57M | ||
| 317.95 | 322.25 | 314.60 | +6.75 | +2.17% | 7.86M | ||
| 196.65 | 197.15 | 192.32 | +5.86 | +3.07% | 34.77M | ||
| 1,408.50 | 1,428.70 | 1,393.00 | -24.20 | -1.69% | 4.94M | ||
| 4,039.30 | 4,097.00 | 3,940.50 | +139.80 | +3.59% | 1.31M | ||
| 3,478.90 | 3,532.30 | 3,390.00 | +113.30 | +3.37% | 1.09M | ||
| 11,204.00 | 11,236.00 | 10,801.00 | +440.00 | +4.09% | 456.44K | ||
| 189.05 | 190.62 | 187.90 | +0.31 | +0.16% | 13.86M | ||
| 1,204.10 | 1,217.80 | 1,180.00 | +20.90 | +1.77% | 1M | ||
| 1,851.80 | 1,867.40 | 1,839.20 | +15.80 | +0.86% | 1.17M | ||
| 612.90 | 617.20 | 603.95 | +9.90 | +1.64% | 2.92M | ||
| 242.18 | 244.50 | 240.01 | +4.24 | +1.78% | 64.77M | ||
| 237.35 | 241.00 | 234.75 | +4.65 | +2.00% | 15.68M |
Investing.com -- Oxford BioMedica (LSE:OXB) has reaffirmed its full-year 2026 guidance, expecting revenue of £220-240 million at...
Investing.com -- Ecora Royalties Plc (LON:ECOR) reported fiscal year 2025 results that exceeded analyst expectations, with...
Investing.com – Japan equities were lower at the close on Thursday, as losses in the Paper & Pulp, Transport and Communication...
Geopolitics is no longer a background risk—it is becoming one of the primary forces shaping the US stock market. From rising...
It’s hard to know what will come next as some markets work bounces off their 200-day MAs, while others struggle below it. The...
The S&P 500 managed a modest gain on Wednesday, but don’t let that fool you — the index has essentially gone...
Company | EPS / Forecast | Revenue / Forecast | Market Cap | Time | ||
|---|---|---|---|---|---|---|
| Thursday, 26 March 2026 | ||||||
PT BUMA Internasional Grup Tbk(DOID) | EPS / Forecast | Revenue / Forecast | -- / -- | -- / -- | ||
CNOOC(0883) | EPS / Forecast | Revenue / Forecast | -- / 0.55 | -- / 98.08B | ||
TS Financial Holding(2887) | EPS / Forecast | Revenue / Forecast | 0.55 / 0.42 | 58.34B / 19.29B | ||
United Renewable Energy(3576) | EPS / Forecast | Revenue / Forecast | -0.14 / -- | 619.04M / -- | ||
CSCC(1723) | EPS / Forecast | Revenue / Forecast | 0.51 / 0.54 | 1.34B / 1.36B | ||
Peoplebio(304840) | EPS / Forecast | Revenue / Forecast | -- / -- | -- / -- | ||
Digi Communications(DIGI) | EPS / Forecast | Revenue / Forecast | -- / -- | -- / -- | ||
Aero Win(8222) | EPS / Forecast | Revenue / Forecast | 0.39 / -- | 234.61M / -- | ||
KSB Pref(KSBG_p) | EPS / Forecast | Revenue / Forecast | -- / -- | -- / -- | ||
Corticeira Amorim(CORA) | EPS / Forecast | Revenue / Forecast | 0.07 / -- | 184.49M / -- | ||